New research suggests it’s never too early to learn healthy eating and exercise habits to reduce the future risk of heart problems. Deepak Bhatt (Brigham and Women’s) wrote an editorial accompanying the study.
Frustrations have been growing as federal requirements for electronic medical records have kicked in and grown teeth — to the point that the American Medical Association has now launched a campaign—called “Break the Red Tape”—to call for a pause on new medical record rules. Ken Mandl (Boston Children’s) is quoted.
This spring the National Institute for Health and Care Excellence, a U.K. advisory entity for the National Health Service often known as NICE, issued guidance stating that home births are safer than hospital births for women who are having their second or later child with a low-risk pregnancy. Neel Shah (Beth Israel Deaconess) is quoted.
Studies have shown that not only do men and women experience certain diseases differently, but also their response to treatments can vary considerably. Paula Johnson, professor of medicine at Brigham and Women’s Hospital, is quoted.
Harvard Medical School is re-evaluating rigid conflict-of-interest rules that aim to shield scientific research from corporate influence amid complaints by some professors that the restrictions slow the process of turning discoveries into research tools and treatments. Eric Campbell (Mass General), Donald Ingber (Wyss Institute), Marcia Angell (HMS) and Charles Serhan (Brigham and Women’s) are quoted.
Mark G. Shrime, instructor in otology and laryngology at Massachusetts Eye and Ear, and John G. Meara, professor of global health and social medicine and professor of surgery at Boston Children’s Hospital, co-authored this article on global poverty.
This week, a controversy was ignited after Turing Pharmaceuticals chief executive Martin Shkreli hiked the price for his drug Daraprim by 4,000 percent. Aaron Kesselheim, associate professor of medicine at Brigham and Women’s Hospital, is quoted.
New studies of two drugs, showing that each works better than the standard treatment for advanced kidney cancer, should lead to changes in patient care, researchers said on Friday. Toni Choueiri, associate professor of medicine at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, is quoted.
